The GH/IGF-1 Axis in Alzheimer's Disease: A Treatable Hormonal Factor in Dementia
GH and IGF-1 deficiency are associated with Alzheimer's disease, with evidence that restoring this axis improves cognitive function — positioning GH secretagogues as potential therapeutic agents for neurodegeneration.
Quick Facts
What This Study Found
GH/IGF-1 axis decline correlates with Alzheimer's disease progression, with IGF-1 supporting neuronal survival, beta-amyloid clearance, and synaptic function — GH secretagogues that restore this axis may offer neuroprotective therapeutic benefit for dementia.
Key Numbers
How They Did This
review study.
Why This Research Matters
Relevant for hormone-optimization, neuroprotection, anti-aging.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding GH/IGF-1 axis decline correlates with Alzheimer's disease progression, with IGF-1 supporting neuronal survival, beta-amyloid clearance, and synaptic f
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2008.
- Original Title:
- Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer's disease.
- Published In:
- Endocrine, metabolic & immune disorders drug targets, 8(2), 143-51 (2008)
- Authors:
- Gómez, José Manuel
- Database ID:
- RPEP-01349
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
The GH/IGF-1 Axis in Alzheimer's Disease: A Treatable Hormonal Factor in Dementia
What was found?
GH and IGF-1 deficiency are associated with Alzheimer's disease, with evidence that restoring this axis improves cognitive function — positioning GH secretagogues as potential therapeutic agents for neurodegeneration.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01349APA
Gómez, José Manuel. (2008). Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer's disease.. Endocrine, metabolic & immune disorders drug targets, 8(2), 143-51.
MLA
Gómez, José Manuel. "Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer's disease.." Endocrine, 2008.
RethinkPeptides
RethinkPeptides Research Database. "Growth hormone and insulin-like growth factor-I as an endocr..." RPEP-01349. Retrieved from https://rethinkpeptides.com/research/gomez-2008-growth-hormone-and-insulinlike
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.